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Abstract:
Background:
Cognitive behavioral group therapy has developed several techniques in order to make the treatment of depressive and anxiety disorders more
effective. Particularly, the “homework” is a tool in order to practice therapeutic skills in ecological settings. When working with this aim, it is often
necessary to support patient compliance.
Researches have shown the efficacy of sending a text to the patients in order to support the patient compliance, but only a few data are available on
the effectiveness of sending text in the treatment of depression and anxiety.
Objective:
Verify the effectiveness of sending text in the treatment of depression and anxiety in order to support patient compliance.
Methods:
Participants were enrolled for cognitive behavioral group therapy. Once completed the treatment, a sub-group of participants (Yes SMS group) was
reached by a weekly text message for the whole 3 months time between the end of the intervention and the scheduled follow-up session.
All the participants were assessed for the overall psychopathological symptoms, depression, and anxiety before and after the group intervention,
and at the 3 months follow up.
Results:
Both groups improved from pre to post-treatment in all the assessed dimensions; the enhancement endures up to the 3 months follow up.
Comparing the two groups regardless of the diagnosis, the Yes SMS group shows significant better outcomes in depression at follow-up and in
anxiety both at post-treatment and at follow-up.
Conclusion:
The weekly SMS as prompt seems to enhance the patient’s compliance.
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1. INTRODUCTION
The  prevalence  of  Anxiety  and  Depression  Disorders  is
high; at a global level, it is estimated that the percentage of the
world’s population suffering from depression is 4.4%, whereas
3.6%  suffer  from  anxiety  [1].  In  Italy,  the  prevalence  at  12
months of each affective disorder is equal to 3.5% (IC 2.9-4.0)
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and  the  prevalence  at  12  months  of  each  anxiety  disorder  is
equal to 5.1% (IC 4.0-6.3) [2]. In both diagnostic categories,
the prevalence is higher for females.
Pharmacological  therapy  is  common  in  the  treatment  of
these  disorders  [3].  However,  it  has  been  observed  that  the
psychopharmacological  approach  has  a  variable  set  of
outcomes,  from  no  response  to  partial  response  [4,  5].
In  consideration  of  the  prevalence  of  depression  and
anxiety and the levels of drug resistance [6, 7], psychological
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therapies are often integrated with pharmacological therapy in
the treatment of these conditions [8, 9].
Cognitive  Behavior  Therapy (CBT [9];  is  an  example  of
the  evidence-based  individual  psychological  intervention  for
depression  and  anxiety  [10  -  12],  often  used  to  supplement
pharmacotherapy.
Even  though  there  is  less  documentation  on  the  effec-
tiveness of Cognitive Behavioral Group Treatments (CBGT),
there are also studies that indicate promising results [13 - 16].
Some relaxation based cognitive behavioral  approaches have
also  some  efficacy  across  a  range  of  clinical  conditions,
including  anxiety  [17]  and  depression  [18,  19].  CBT  for
depression and anxiety can easily be applied in group settings,
which may prove more cost-effective [19, 20].
CBT  uses  techniques  whose  effectiveness  is  verified
experimentally.  Over  time,  CBT  both  individual  and  as  a
group- has developed several techniques in order to make the
treatment more effective. In particular, the “home- work” is a
tool  used to  practice  therapeutic  skills  in  ecological  settings.
When working with this aim, it  is often necessary to support
the patient’s compliance.
The  use  of  Short  Message  Service  (SMS  or  text  messa-
ging)  is  a  relatively  recent  possibility  to  support  compliance
and  in  general  to  support  welfare  and  health  promotion
treatments  [as  a  matter  of  fact,  the  first  study  on  the
effectiveness of text messages in the treatment of asthma dates
back  to  2002  [21]  and  the  first  randomized  clinical  trial  on
smoking cessation was carried out in 2005 [22].
Delivering  strategies  via  mobile-phone  technology  is
particularly  interesting  because  the  use  of  mobiles  is  ext-
remely  widespread,  also  among  Italians  [23].
Various studies have shown the effectiveness of sending a
text  to  patients  in  order  to  support  their  compliance.  For
instance,  Webb,  Joseph,  Yardley,  and  Michie  [24]  highlight
that  the  effectiveness  of  Internet-based  treatments  has  been
enhanced  by  using  additional  methods  of  communication,
among  which  the  use  of  SMS.
The available literature on the effectiveness of the use of
SMS is however mostly medical setting focused and only a few
data  are  available  on  the  effectiveness  of  the  SMS  in
depression  and  anxiety  disorders.
Although  text  messages  can  be  used  for  different  pur-
poses  [25],  they  have  often  been  used  for  behavior  modi-
fication; for instance to promote smoking cessation [26, 27], to
support physical activity [28, 29], send motivational messages
[30], provide a cue to action [31], or for improving treatment
adherence in schizophrenia [32, 33].
Webb  et  al.  [24]  suggest  that  personal  contact  via  text
message could support behavior change and influence in this
way health behavior at any time.
The aim of this study is to verify the effectiveness of the
SMS  in  order  to  support  patient’s  compliance  in  exercising
relaxation and mindfulness, comparing two outpatient groups
who underwent  the  same  treatment  (CBGT),  but  where  only
one group received a motivational weekly SMS.
2. MATERIALS AND METHODS
2.1. Participants
Seventy-nine participants (24 males and 55 females; mean
age  49.86,  ±11.80)  were  recruited  initially.  Patients  had
received  a  diagnosis  of  either  Anxiety  Disorder  (N=  32;  10
males  and  22  females)  or  Depressive  Disorder  (N=  47;  14
males e 33 females).
The diagnostic categories, in according to DSM 5, among
anxiety disorders were Generalized Anxiety Disorder (N=15),
Unspecified  Anxiety  Disorder  (N  =  9),  and  Adjustment
Disorder  with  anxiety  symptoms  (N=8).  The  diagnostic
categories  among  the  depressive  disorders  were:  Persistent
Depressive Disorder with anxious distress (N=21), Persistent
Depressive Disorder (N=2), Major Depressive Disorder (tot 24:
Single Episode N=14, Recurrent Episode = 10).
After  the  psychological  treatment,  a  subgroup  of  39
participants  out  of  79  (Yes  SMS  Group)  was  reached  by  a
weekly  SMS.  The  mean  age  of  this  subgroup  was  49.61
(±13.43),  with  14 males  and 25 females;  16  participants  had
received a diagnosis of anxiety and 23 of depressive disorder;
the second subgroup (No SMS Group) had a mean age of 50.0
(± 11.01), with 10 males and 30 females; 16 participants had
received a diagnosis of anxiety and 24 of depressive disorder.
All  the  psychiatric  diagnoses  have  been  made  through
psychiatric interviews conducted by senior Psychiatrists, who
are unrelated to this study, not using psychiatric tests.
2.1.1. Inclusion Criteria
Age  between  18  and  65;  established  the  diagnosis  of
Anxiety  or  Depression,  signed  informed  consent  and  partial
response  to  pharmacological  treatment  (following  the  guide-
lines [34 - 36]. All patients had received at least two cycles of
drug  treatment  with  adequate  duration  and  dosage  for  each
cycle  as  indicated  by  the  guidelines,  for  a  mean  period  of  3
months prior to their referral to the psychological outpatients
Unit.
2.1.2. Exclusion Criteria
Personality  disorders,  intellectual  disability  comorbi-
dities,  drug/alcohol  addiction,  schizophrenia  and  other
psychotic  disorders,  and/or  anxiety  and  depressive  disorders
due to medical condition.
2.2. Materials
2.2.1. Symptom Checklist 90 R (SCL-90 R [37])
A 90-item self-report instrument evaluating nine symptom
dimensions:  Somatization,  Obsessive-Compulsive,  Interper-
sonal  Sensitivity,  Depression,  Anxiety,  Hostility,  Phobic
Anxiety, Paranoid Ideation, and Psychoticism. The sum of the
90 items produces the Global Severity Index (GSI), a measure
of  overall  psychological  distress.  The  internal  reliability
(Cronbach  α)  of  the  scales  ranges  from  0.74  for  hostility  to
0.97 for the GSI [38]. However, factor analytic studies of the
Italian  version  have  suggested  that  the  GSI  is  an  optimal
measure  for  the  assessment  of  distress  symptoms  [39].
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2.2.2. Beck Depression Inventory (BDI [40])
A  21  item  self-report  rating  inventory  that  assesses  the
clinical symptoms of depression by asking about feelings over
the  past  week.  The  score  is  a  sum  of  the  positive  answers,
ranging from 0 to 63, and scores of 10 or greater reflects the
presence of some level of depression. The internal reliability
(Cronbach  α)  of  the  scale  is  between  0.73  and  0.92,  and  a
concurrent validity between 0.55 and 0.73 for non-psychiatric
subjects [41].
2.2.3. Hamilton Depression Rating Scale (HAMD [42])
A  21  item  clinician-administered  questionnaire  used  to
indicate depression and evaluate recovery in adults. Scores of 8
or higher indicate depression, and a non-clinical Italian sample
has been found to have a mean score of 3.5 [43]. The scale has
an internal reliability range of 0.46-0.97 [44].
2.2.4. Hamilton Anxiety Rating Scale (HAMA [45])
A 14 item clinician-administered questionnaire to indicate
adult  anxiety  and  recovery.  Scores  of  8  or  higher  indicate
anxiety [46], and a nonclinical Italian sample has been found to
have  a  mean  score  of  3.6  [43].  The  scale  has  an  internal
reliability  range  of  0.74-  0.96  [47].
2.2.5. Self-rating Anxiety Scale (SAS [48])
A 20-item self-report scale that assesses primarily somatic
symptoms associated with anxiety symptoms. The respondent
indicates how often (s)he has experienced each symptom on a
4-point Likert scale consisting of “none or a little of the time”
(coded as 1), “some of the time” (coded as 2), “good part of the
time” (coded as 3), and “most or all of the time” (coded as 4).
The raw total score range is 0–80. In a clinical sample, the test-
retest reliability ranges between .81 and .84 over a period of 1
to 16 weeks [49].
2.2.6. The State-Trait Anxiety Inventory (STAI [50])
A  40  item  self-report  measure  of  anxiety.  All  items  are
rated on a 4 point scale (e.g., from “Almost Never” to “Almost
Always”). Internal consistency coefficients for the scale have
ranged  from  0.86  to  0.95;  test-retest  reliability  coefficients
have  ranged from 0.65 to  0.75 over  a  2-month  interval  [50].
Evidence attests to the construct and concurrent validity of the
scale [51].
2.3. Procedure
On referral to the Psychological Unit the patients have all
been given information on the treatment and the current study.
All  outpatients  have  been  enrolled  for  an  8-weekly  sessions
group  treatment  (2-hour  group-based  session  a  week)  while
following their  pharmacological TAU (Treatment As Usual).
Patients  have  been  treated  with  conventional  doses  of
medication, mainly those recommended for the treatment and,
during the group treatment, there have been no major changes
in the pharmacotherapy. Each session has been run by two co-
therapists: a psychotherapist and a psychologist.
All the 79 participants have been assessed for the overall
psychopathological symptoms, depression, and anxiety before
and after the group treatment, and at the 3-months follow-up.
2.3.1. Treatment
The program has been modeled after the clinical programs
of the Benson-Henry Institute for Mind Body Medicine at the
Massachusetts General Hospital [52, 53]. The training has been
designed  to  provide  tools  for  symptom  management  in
outpatients. In the program, patients have been taught a variety
of techniques aimed at helping them with their psychological
symptoms and as a self-regulatory integrated approach to stress
reduction  and  emotion  management  including:  psychoedu-
cation on different topics, from stress to lifestyle well-being;
relaxation techniques;  mindfulness  techniques;  and cognitive
restructuring techniques.
The treatment is described in detail in a study by Truzoli,
et al., [16].
Upon  completion  of  the  treatment,  at  the  end  of  the  8
expected weeks, a subgroup of 39 participants out of 79 (Yes
SMS Group) was reached by a weekly SMS for  the whole 3
month-period  between  the  end  of  the  treatment  and  the
scheduled  follow-up  session.  The  Yes  SMS  Group  was  not
selected randomly, but according to the date of arrival to the
Psychology Unit after being referred by psychiatrists.
The  text  sent  by  SMS  was:  “Vi  incoraggiamo  a  conti-
nuare  gli  esercizi  anche  questa  settimana.  Praticare  il  ril-
assamento  e  la  mindfulness  migliora  il  vostro  benessere”
(translation: We encourage you to continue the exercises also
this week. Practicing relaxation and mindfulness increases your
well-being.)  The  text  message  was  sent  at  5.00  pm  every
Tuesday.
2.3.2. Statistical Analysis
To compare the two subgroup the Mann-Whitney test has
been  used.  The  effect  sizes  (d  [54];)  for  post-treatment
differences between the phases has been calculated in line with
Cochrane  recommendations  [55];  in  our  case,  pre-test  and
three-month  test  data  have  been  used.
3. RESULTS
All participants concluded the treatment and participated in
the follow-up.
The  pre-test  between  the  Yes  SMS  Anxiety  and  the  No
SMS Anxiety subgroups showed no significant differences in
all tests (Mann-Whitney Test: all ps >.06); in the same way, by
comparing  the  Yes  SMS  Depression  and  the  No  SMS  Dep-
ression subgroups, no significant differences have emerged in
all tests (Mann-Whitney Test: all ps >.55).
In addition, in the pre-test between the Yes SMS Anxiety
and the Yes SMS Depression subgroups, and between the No
SMS Anxiety  and  the  No  SMS Depression  subgroups,  there
have  been  no  significant  differences  in  all  tests.  (Mann-
Whitney  Test:  all  ps  >.10).
In  pre-test  in  Yes  SMS  group  and  No  SMS  group,  the
mean of all the used scales falls within a clinical range.
Table 1  for the Yes SMS and No SMS groups shows the
means and standard deviations of all the tests used for the three
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Table 1. Mean (standard deviations) for overall symptoms (SCL-90 R), depression and anxiety in pre, post and follow-up
treatment, as well as the percentage (%) of improvement between pre-test and follow-up, and effect size (d) comparing the
pre-test and the follow-up, for the Yes SMS and No SMS groups.
–
Yes SMS No SMS
    Pre Post Follow     % d Pre Post Follow     % d
Symptom
Number
87.87
(54.01)
57.6
(35.10)
57.92
(39.42)
34.08 0.64
99.8
(43.15)
66.57
(39.15)
70.2
(43.98)
29.66 0.68
Depression
(BDI)
15.67
   (8.91)
10.65
(5.84)
11.36
(6.86)
  27.50 0.55
  15.67
  (7.70)
11.72
(7.89)
12.1
(8.08)
  22.78 0.45
Depression
(Hamilton)
  17.69
(4.39)
12.4
(4.48)
  9.88*
(4.25)
44.15 1.81
  18.67
  (6.24)
11.92
(5.23)
12.47
(4.92)
33.21 1.11
Anxiety
(Hamilton)
  13.78
  (4.22)
9.24*
(3.54)
8.24**
(3.65)
  40.20 1.41
   18.17
   (5.62)
11.07
(4.97)
12.01
(4.65)
  33.90 1.20
Anxiety
(SAS)
  38.56
(9.59)
33.64
(8.23)
34.24
(8.07)
11.20 0.49
  42.38
  (7.68)
37.16
(5.88)
38.05
(8.43)
10.22 0.54
Anxiety
(STAI)
  92.12
  (19.68)
84.44
(19.70)
82.97
(15.43)
  9.93 0.52
  98.22
(21.43)
88.95
(23.35)
88.37
(20.72)
  10.03 0.47
Legenda
Comparison of Yes SMS with No SMS groups using the Mann-Whitney test: *p < .05; ** p < .0001
In bold the boxes with significant differences.
Table 2. Mean (standard deviations) for overall symptoms (SCL-90 R), depression, and anxiety for the Yes SMS Depression
and No SMS Depression subgroups in pre, post and follow-up treatment.
–
Yes SMS
Depression
No SMS
Depression
– Pre Post Follow-up Pre Post Follow-up
Symptom
Number
91.47
(66.04)
59.8
(40.12)
56.66
(39.99)
100.83 (42.86)
61.16
(32.52)
67.73
(37.23)
Depression
(BDI)
17.04
(9.95)
10.93
(5.43)
12.73
(6.82)
16.04
(8.02)
13.41
(8.48)
12.08
(8.44)
Depression
(Hamilton)
17.42
(5.17)
11.8
(4.47)
9.73
(4.47)
18.00
(5.32)
11.83
(5.91)
12.33
(5.46)
Anxiety
(Hamilton)
15.78
(5.93)
9.46
(3.79)
8.0*
(4.19)
18.37
(5.84)
10.33
(4.74)
12.25
(5.39)
Anxiety
(SAS)
38.52 (11.37)
35.26
(9.16)
34.06
(8.20)
41.95
(8.75)
36.40
(6.04)
37.73
(8.75)
Anxiety
(STAI)
91.06 (21.23)
83.13
(18.75)
85.26
(16.31)
99.58
(22.58)
88.54
(20.25)
87.66
(20.33)
Legenda
Comparison of Yes SMS Depression with No SMS Depression subgroups using the Mann-Whitney test: *p < .05
In bold the boxes with significant differences.
phases (pre, post and follow-up), the percentages of improve-
ment between pre-test and follow-up, and the ‘d’ values (effect
size) comparing the pre-test and the follow-up.
As  indicated  in  Legenda  (Table  1),  comparing  the  Yes
SMS with the No SMS groups using the Mann-Whitney test,
significant differences have arisen for the HAMD test follow-
up (z = -2.35); the HAMA post-test (z = -2.26) and follow-up
(z = -4.02).
As described in Participants section, Yes SMS group and
No  SMS  group  substantially  consist  of  the  same  number  of
participants  diagnosed  with  depression  or  with  anxiety;  in
addition to this, in pre-test the mean of all the used scales fall
within  a  clinical  range.  Thus,  the  number  of  participants  in
each diagnostic class of the two groups and the initial clinical
situation of the participants are unlikely to have a significant
influence on the results of the comparison.
Regarding  the  percentage  of  improvement,  both  groups
have  improved,  showing  a  greater  improvement  for  the  Yes
SMS group for almost all the tests used. It should be noted that
the improvement is the result of the comparison between pre-
test and follow-up. As a consequence, the outcome reflects the
improvement produced by the treatment combined with SMS.
The ‘d’ values are medium for SCL - 90 R, around medium
for  BDI,  SAS  and  STAI;  large  for  HAMD and  HAMA,  but
larger for Yes SMS Group.
Table  2  for  the  Yes  SMS  Depression  and  No  SMS
Depression  subgroups  shows  the  means  and  standard
deviations  of  all  the  tests  used  for  the  three  phases.
Comparing  the  Yes  SMS  Depression  with  No  SMS
Depression subgroups using the Mann-Whitney test, significant
differences have emerged for the HAMA test at follow-up (z =
-2.46).  Regarding  the  assessment  of  depression,  it  should  be
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noted  that  each  of  the  two  groups  improves  from pre-test  to
follow up, but no significant differences emerge between the
two  groups.  This  result  will  be  analyzed  in  detail  in  the
Discussion.  Reference  will  also  be  made  to  the  type  of  text
message  sent,  and  to  the  differences  between self-report  and
clinician-rated scales.
Table 3 shows the means and standard deviations of all the
tests  used  for  the  three  phases  for  the  subgroups  Yes  SMS
Anxiety and No SMS Anxiety.
Comparing the Yes SMS Anxiety with No SMS Anxiety
subgroups using the Mann-Whitney test, significant differences
have arisen for the HAMD test at follow-up (z = -2.04), and for
the HAMA post-test (z = -2.01), and for the HAMA follow-up
(z = -3.47).
4. DISCUSSION
The results have demonstrated that the treatment has had
good patient acceptability, where no participant dropped out of
the cognitive behavioral group treatment.
Both groups (Yes SMS and No SMS) have improved from
pre to follow-up treatment in all the assessed dimensions (see
improvement  percentages  and effect  size).  Such a  result  was
expected in consideration of the previous evidence [15].
It is interesting to highlight the fact that the weekly SMS,
used as a prompt, has seemed to work as simple and effective
support for patients.
Comparing  the  two  groups  (Yes  SMS  and  No  SMS),
regardless  of  the  diagnosis,  the  Yes  SMS  group  has  shown
significantly better outcomes in depression (HAMD) at follow-
up,  and  in  anxiety  (HAMA)  both  at  post-treatment  and  at
follow-up.
Comparing  the  two  subgroups  taking  into  account  the
diagnoses, the subgroup Yes SMS - diagnosis of anxiety – has
shown significant better outcomes in anxiety (HA- MA) at post
and at follow-up and in depression (HAMD) at follow-up; the
subgroup  Yes  SMS -  diagnosis  of  depression  -  shows  better
outcomes in anxiety (HAMA) at follow-up.
The evidence that the Yes SMS Anxiety subgroup has also
improved  depressive  symptomatology  at  follow-up  can  be
explained  by  the  fact  that  if  anxiety  is  reduced,  patients
improve their overall  well-being by recovering the hope of a
better  life,  with  beneficial  effects  on  their  mood.  A  similar
mechanism  may  explain  the  evidence  that  the  Yes  SMS
Depression  group  has  improved  anxious  symptomatology  at
follow-up.
It should not be excluded that the treatment and practice of
relaxation  and  mindfulness  exercises  has  influenced  the
symptomatic area common to depression and anxiety (features
that  overlap  in  the  two  diagnostic  classes  such  as  muscle
tension,  sleep  disorders,  asthenia,  irritability,  etc.).
Moreover, in relation to the comparison between Yes SMS
Depression  and  No  SMS  Depression  subgroups  significant
differences have emerged for the HAMA test only. It should be
noted that all participants with depression improve depressive
symptoms;  so,  we  can  hypothesize  that  this  has  a  reassuring
effect, with greater impact on the anxious component when the
treatment is associated with sending SMS.
Furthermore,  it  could  be  assumed  that  sending  targeted
SMS could be more effective on the mood.
Indeed Head, Noar, Iannarino, and Grant Harrington [56]
indicate that the mean effect size of text messaging in health
promotion  interventions  gets  close  to  medium magnitude.  In
addition, they observed that the larger effect sizes have been
found  with  tailored  messages  (messages  aimed  at  a  specific
individual, or based on specific demographic and psychosocial
variables) or targeted (messages aimed at a specific group, such
as smokers or depressed people). Also the use of personalized
strategies – such as using the name of the participants - seems
to  be  useful  to  improve  the  effectiveness  of  the  SMS  [57].
Finally, Head et al. [56] suggest taking into consideration the
possibility to plan the timing of when to send text messages in
relation to the behavior to be supported (for example, at the end
of the working day when a person has to decide whether or not
to go to the gym).
Thus, considering the typology of participants in this study,
it will be interesting to investigate the differential effectiveness
of  changes  in  the  content  of  the  SMS  message  and  the
scheduled time for messaging. It could be possible to make the
SMS  more  personalized  (using  the  participant’s  name)  and
more  tailored  with  respect  to  the  diagnosis  (for  example,
possible mood improvements for participants with depression
and possible improvements on worries for participants with a
diagnosis  of  anxiety can be highlighted).  Finally,  it  could be
possible  to  better  assess  the  time at  which text  messages  are
sent  based  on  demographic  factors,  such  as  the  profile  of
housewife,  unemployed  or  employed.
This study employed clinician-rated and patient self-report
measures of depression and anxiety.
The  differences  between  the  scales,  which  are  not
completely  overlapping,  may  partially  explain  the  incon-
sistent  results  between  the  scales  in  both  depression  and
anxiety
A symptomatological  improvement has been detected on
both  types  of  scales,  but  there  have  been  some  differences
between  the  degree  to  which  symptoms  have  been  shown to
improve  according  to  clinician-rated  and  patient-rated  scales
(outcomes  of  the  clinician-rated  scales  are  higher  than  self-
report  outcomes).  However,  it  is  well  known  that  in  the
depressive disorder area, the agreement between self-reported
and clinician-rated measures is far from perfect, even though
there  is  a  correlation  rated  from moderate  to  strong between
clinician-rated scales and self-reported questionnaires [58 - 60].
It  could  be  assumed  that  this  is  the  case  for  the  Anxiety
Disorders  as  well  [61].
There could be many reasons for these differences, such as
a)  slightly  different  foci  of  the  questionnaires  used  by
clinicians and patients,  and b) the degree to which particular
symptoms may be regarded as important to the patents in their
own functioning.
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Table 3. Mean (standard deviations) for overall symptoms (SCL-90 R), depression, and anxiety for the Yes SMS Anxiety and
No SMS Anxiety subgroups in pre, post and follow-up treatment.
– Yes SMS Anxiety No SMS Anxiety
– Pre Post Follow-up Pre Post Follow-up
Symptom
Number
79.53
(30.94)
54.3
(27.60)
59.08
(40.61)
98.25
(44.93)
74.68
(47.39)
77.87
(52.39)
Depression
(BDI)
13
(6.49)
10
(6.71)
9.3
(6.71)
15.12
(7.39)
9.18
(6.31)
12.12
(7.77)
Depression
(Hamilton)
18.07
(3.06)
13.3
(4.57)
10.1*
(4.12)
18.00
(7.54)
12.06
(4.17)
12.68
(4.14)
Anxiety
(Hamilton)
14.84
(3.07)
8.09*
(3.28)
8.6**
(2.83)
16.93
(4.78)
12.18
(5.24)
11.87
(3.38)
Anxiety
(SAS)
37.07
(6.81)
31.02
(6.23)
34.55
(8.30)
43.0
(6.0)
38.29
(5.63)
38.12
(8.21)
Anxiety
(STAI)
93.7
(18.07)
86.4
(21.91)
79
(12.40)
96.18
(20.10)
89.56
(28.06)
89.43
(21.89)
Legenda
Comparison of Yes SMS Anxiety with No SMS Anxiety subgroups using the Mann-Whitney test: *p < .05; ** p < .0001
In bold the boxes with significant differences.
In any case, it is reassuring that even at a lower level, there
has  been  a  symptomatic  improvement  even  on  patient-rated
scales.
CONCLUSION
The clinical effect of the treatment can be assessed overall
as  positive.  As  was  expected,  the  brief  multi-component
program  has  been  successful  with  those  patients  who  prev-
iously had shown little change in their symptomatology with
pharmacotherapy, despite the fact that patients had been under
the same drug treatment dosage the previous three months and
during  the  whole  period  of  group  treatment.  Symptoms  of
Anxiety  and  Depression  can  be  modulated  and  reduced  by
learning self-management and self-regulation skills. This short-
term treatment offers a cost-effective tool for treating the most
common psychiatric disorders claimed in public health settings.
If  we  compare  this  work  with  previous  ones,  this  study
adds some evidence of the effectiveness of adding the use of
SMS  to  motivate  participants  to  perform  relaxation  and
mindfulness exercises.  This effect can also be traced back to
the fact that people feel better treated even after the end of the
therapeutic  process.  This  supports  the  compliance  with  the
therapeutic indications that implies inserting exercise into the
daily routine.
A future hypothesis to be verified could be a change in the
content  and  timing  of  sending  SMS messages,  as  previously
discussed.
Finally,  it  should  be  highlighted  that,  unlike  several
studies, which have used only patient self-report measures of
depression and anxiety, this study has also employed clinician-
rated  measures.  Uher,  Perlis,  Placentino,  Dernovsek,  Heni-
gsberg,  Mors,  Maier,  McGuffin,  and  Farmer  [62]  has
highlighted  that  self-report  and  clinician-rated  outcomes  are
not equivalent, each of the two providing unique information
that  is  relevant  to  the  clinical  analysis.  In  general,  the  most
accurate  prediction of  outcomes can be  achieved when both,
clinician and self-rating assessments, are available [54].
STUDY LIMITATION
A first  observation  concerns  the  fact  that  the  patients  to
whom the text messages have been sent, had not been chosen
randomly.  This  reflects  the observational  nature of  the study
and the usual clinical practice in mental health services; in any
case,  the  two  groups  equaled  at  the  pre-test  in  the  variables
studied.
A second limitation is that the sample size when patients
are split into two diagnostic classes is small, and so the results
should be interpreted with caution.
Another  limitation is  the  lack of  a  control  group;  so,  the
gathering of data from the control group can be a future goal.
In any case, the improvement after CBGT with respect to
the  baseline,  when  participants  had  undergone  only  the
psychopharmacological  treatment,  suggests  that  it  might  be
useful to integrate it with the pharmacological approach. The
proposed treatment  could,  therefore,  be considered as  one of
the tools available to the clinician to work in the perspective of
integrated treatments.
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